• 28 B, rue du Thabor, 35000 Rennes
  • Contact@slbpharma.com

Medical devices

Biomedical services

Our experience at your fingertips

The Medical Device (MD) sector is a dynamic market. It is in a state of growth and heavily involved in Health Innovation (diagnosis, surgery, therapeutics, etc.). As a result, the scientific standard of proof has inevitably improved in light of the strengthening of legislation, which is always in the interests of the patient (Directive 2007/47/EC).

Unlike the pharmaceutical industry, the heterogeneity of the MD world makes it a complex and specific sector that requires experience and skills to accurately assess its clinical performance.

The clinical study of the MD must be adapted not only to its status (i.e. its classification), but also to its development strategy, which should be set out in advance in order to save time when placing it on the market and positioning it.

SLB Pharma has the necessary knowledge (DM IIa, IIb, III, DMIA DMDIV and software), allowing you to gain access to all the expertise you need to meet your expectations:

dot Evaluation for CE marking approval,
dot Evaluation for renewal of CE marking approval,
Post-registration research study with respect to a request for support (CNEDiMTS – Medical Device and Health Technology Evaluation Committee)
Usage survey / field survey / satisfaction survey, etc.

We also place an emphasis on our specialised and recurrent clinical experience in the very specific areas of orthopaedics and dentistry (functional orthodontic appliance, implants, equipment and software).

We conduct all clinical studies with the same quality as research into pharmaceuticals, within specific deadlines, and at a cost that is compatible with the MD market.

Anne-Laure Sérandour, PhD – your preferred contact person for the clinical evaluation of your medical devices.

“ In order to achieve a well-designed clinical evaluation, SLB Pharma will listen, understand and carry out a clinical reformulation of the needs of the client. These exchanges and a close cooperation during the project conception phase ensure that the methodology, financial aspects and timelines are properly scaled for each evaluation ”

To learn more about our services

SLB PHARMA  benefits from the Research Tax Credit agreement.